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S U M M A R Y
Background: A high prevalence of Helicobacter pylori in the esophageal mucosa of dyspeptic Venezuelan
patients has been reported. We aimed to assess the genetic composition of the cag genotypes of H. pylori
and its relation to histopathological outcomes in the gastroesophageal mucosa.
Methods: The presence of cagA, cagE, and virB11 cag pathogenicity island (PAI) genes was detected by
PCR in 80 of 150 H. pylori-positive dyspeptic patients in both mucosae. Alterations of the
gastroesophageal mucosa were assessed by histological techniques.
Results: The frequency of intact, partial, and deleted cag-PAI genes in the stomach of dyspeptic patients
was found to be 57.5%, 21.3%, and 21.3%, respectively, whereas in the esophagus, frequencies were 33.8%,
33.8%, and 32.5% respectively. The genetic composition in the stomach was 57.5% cagA-positive, 20.0%
cagA-negative, 75.0% cagE, and 77.5% virB11, whereas in the esophagus the distribution was 36.3% cagA-
positive, 30.0% cagA-negative, 61.3% cagE, and 63.8% virB11. The gene with the largest difference
between the two mucosae was cagA, with 58.8% in the stomach and 37.5% in the esophagus; cagE and
virB11 were less variable. The correlation among single and/or mixed cag genotypes with
histopathological outcomes in both mucosae from the same patient was higher for intact single cag-
PAI genotypes, showing severe alterations.
Conclusions: H. pylori may coexist in similar proportions without dominance of one cag genotype,
suggesting a heterogeneous distribution in the esophagus. The cagE and virB11 genes can be used as
markers of cag-PAI in the esophagus. The single cag-PAI genotype in both mucosae confers an increased
risk of developing histological damage.
 2014 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/3.0/).
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Helicobacter pylori colonizes the gastric mucosa of humans, and
if not treated, persists throughout life.1,2 H. pylori infection has
been implicated as the main cause of peptic ulceration, gastric
lymphoma, and gastric adenocarcinoma, the second leading cause
of death from cancer worldwide.1 More than 50% of the world* Corresponding author.
E-mail address: mocontre@ivic.gob.ve (M. Contreras).
http://dx.doi.org/10.1016/j.ijid.2014.03.1387
1201-9712/ 2014 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).population carries H. pylori, with a prevalence as high as 90% in
developing countries.3 Although most infected persons remain
asymptomatic, 15–20% of H. pylori-positive individuals will
develop at least one of the associated diseases at some point in
their lives.4
One of the disease-associated factors in H. pylori is the presence
of the cag pathogenicity island (cag-PAI),5 which confers an
increased risk for peptic ulcer disease and gastric cancer.2,4,6 This
cag-PAI comprises 31 genes, encoding a functional type IV
secretion system.5 Three of these cag genes (cagA, cagE, and
virB11) have been recognized as markers of an intact cag-PAI.2,4,6ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Table 1
Analyses of cag genotypes in the gastric and esophageal mucosa of 80 patients
studied by PCR
Genotypes Gastroesophageal mucosa (n = 80)
cagA cagE virB11 % of gastric
biopsies (n)
% of esophageal
biopsies (n)
Pos Pos Pos 57.50 (46) 33.75 (27)
Neg Pos Pos 17.50 (14) 27.50 (22)
Neg Neg Pos 2.50 (2) 2.50 (2)
Pos Neg Neg 1.25 (1) 1.25 (1)
Pos Neg Pos 0 (0) 2.50 (2)
Neg Neg Neg 21.25 (17) 32.50 (26)
Pos, positive; Neg, negative.
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individual and even in a single gastric biopsy specimen.7 Gastric
colonization by multiple H. pylori strains is common in countries
where H. pylori is highly prevalent, carrying virulence genotypes
with genetic diversity, as has been demonstrated in infected
patients in Venezuela.8,9
In the upper gastrointestinal tract, the esophagus is a potential
site for the presence of a bacterial biota and may provide a niche for
colonization by H. pylori.10 This bacterium has been detected in
esophagus mucosa biopsies from patients with symptoms of
dyspepsia in the range of 34% to 73%.11,12 However, its role in
esophageal diseases, such as heterotopic gastric mucosa in the
upper esophagus (inlet patch), gastroesophageal reﬂux diseases
(GERD), Barrett’s esophagus, and esophageal carcinoma has not yet
been determined.11,13 We have previously reported an H. pylori
prevalence of 86% in esophageal mucosa biopsies from dyspeptic
patients in Venezuela, and its presence was correlated with signs of
inﬂammation.14 In the present study, we further investigated the
genetic composition of the cag genotype proﬁles of H. pylori through
the detection of cagA, cagE, and virB11 genes by PCR in the
gastroesophageal mucosa, and its relation to histopathological
outcomes at the individual level and among the population studied.
2. Methods
2.1. Clinical specimens
Patients consulting the Gastroenterology Unit of the Oncology
Service Hospital of IVSS (Instituto Venezolano de los Seguros
Sociales) with gastrointestinal symptoms of dyspepsia, requiring
upper gastrointestinal endoscopy, were recruited into this study. All
volunteers signed an informed consent form. The bioethics
committees of the IVIC (Instituto Venezolano de Investigaciones
Cientı´ﬁcas) and IVSS approved the study. Patients who had
previously received treatment were excluded. The study was
performed on 150 volunteers aged 19–69 years (mean age 43 years).
Two paired biopsy sets from the gastric mucosa (antrum) and
esophageal mucosa (lower third or within 2 cm of the Z-line),
performed as described previously,14 were collected from each
patient. For each mucosa, one biopsy specimen was immediately
placed in formalin for histopathology, and the other was submitted
to PCR assays. Biopsies were taken with care to avoid inter-sample
contamination.
2.2. DNA extraction and PCR
A total of 300 DNA samples from 150 patients were processed
using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA, USA).
Helicobacter spp and H. pylori infection were detected by PCR for all
three 16S rRNA, glmM, and ureA genes, using genus- and species-
speciﬁc primers.15–17 The presence of cagA, cagE, and virB11 cag-
PAI genes was investigated in 80 H. pylori-positive patients in both
mucosae using speciﬁc primers described for each gene.6,18
PCRs were performed using the PCR Master Mix Kit (Promega
Corp., Madison, WI, USA) and a thermal cycler (model GeneAMP
PCR System 9700; Applied Biosystems, USA), as described
previously.14 According to the genetic composition of the cag
island by PCR, we considered an intact cag-PAI to be one where all
three genes (cagA, cagE, and virB11) were present, a partial cag
island to be one where at least one gene was lacking, and a deleted
cag island to be one where all three genes were absent.
2.3. Histopathology
All gastric and esophageal biopsy specimens submitted for
histopathology analysis were ﬁxed in formalin and embedded inparafﬁn. Sections of 4 mm in thickness were obtained and adhered
onto glass slides, dewaxed in xylene, and subsequently rehydrated
in phosphate buffer solution at pH 7.4. The sections were assessed
by conventional histological techniques. Histological classiﬁcation
was done according to the updated Sydney classiﬁcation for the
stomach (antrum), and the pattern of inﬂammation in the
esophagus was determined as described by Contreras et al.14
2.4. Statistical analysis
The statistical relationship between different histopathological
parameters and the detection of cag-PAI genotypes was performed
using Spearman’s rank correlation. p-Values of <0.05 were
considered signiﬁcant. The presence of a histopathological
variable, grade-independent, was considered as positive (= 1).
3. Results
3.1. Detection of H. pylori and presence of cag-PAI genes: cagA, cagE,
and virB11
The prevalence of H. pylori infection in the gastric and
esophageal mucosae of 150 dyspeptic patients, as determined
by ampliﬁcation of 16S rRNA, glmM, and ureA genes, was 53.3%
(n = 80) positive in both mucosae; 34.0% (n = 51) were negative in
both mucosal samples, 11.3% (n = 17) were positive only in the
gastric mucosa, and 1.3% (n = 2) were positive only in the
esophageal mucosa. Thus, we studied the cag-PAI gene composi-
tion of the 80 H. pylori-positive patients.
An intact cag-PAI was detected by PCR in 57.5% of stomach
biopsies and 33.8% of esophagus biopsies. Partial deletions of cag-
PAI were present in 21.3% and 33.8%, whereas complete deletions
of cag-PAI were found in 21.3% and 32.5%, respectively (Table 1).
Analysis of the cag genotypes showed that the most frequent
genotypes in the stomach were cagA-positive (57.5%) and cagA-
negative (20.0%), with both of the other two genes studied present
(cagE 75.0% and virB11 77.5%). Similarly in the esophagus,
frequencies of 36.3% and 30.0% were found for cagA-positive
and negative genotypes, respectively, with 61.3% for cagE and
63.8% for virB11 (Table 1).
When we examined the distribution of the cag genotype
proﬁles in the gastroesophageal mucosa on a per-patient basis, we
found 50% of patients to be carrying a single genotype with the
same genetic composition of cag-PAI in stomach and esophagus;
the other 50% carried mixed genotypes with different cag-PAI
composition in the two mucosae (Table 2). The prevalence in the
single cag genotype proﬁle with an intact cag-PAI was 60.0% and
with a deleted cag island was 32.5%. The gene with the largest
difference between the two mucosae in the mixed genotype was
cagA with 57.5% in stomach and 15.0% in esophagus, while cagE
and virB11 were less variable. The cagE and virB11 genes in the
Table 2
Distribution of cag genotype proﬁles in the gastroesophageal mucosa of the same
patient by PCR
PCR results of cag genotypes in mucosa
% of H. pylori-positive
patients (n = 80)
Gastric Esophageal
cagA cagE virB11 cagA cagE virB11
Single cag (n = 40)
60.0 (24) Pos Pos Pos Pos Pos Pos
7.5 (3) Neg Pos Pos Neg Pos Pos
32.5 (13) Neg Neg Neg Neg Neg Neg
Mixed cag (n = 40)
42.5 (17) Pos Pos Pos Neg Pos Pos
7.5 (3) Pos Pos Pos Neg Neg Neg
5.0 (2) Pos Pos Pos Pos Neg Pos
17.5 (7) Neg Pos Pos Neg Neg Neg
5.0 (2) Neg Pos Pos Pos Pos Pos
2.5 (1) Neg Pos Pos Pos Neg Neg
2.5 (1) Neg Pos Pos Neg Neg Pos
5.0 (2) Neg Neg Neg Neg Pos Pos
2.5 (1) Neg Neg Neg Neg Neg Pos
2.5 (1) Neg Neg Neg Pos Pos Pos
5.0 (2) Neg Neg Pos Neg Neg Neg
2.5 (1) Pos Neg Neg Neg Neg Neg
Pos, positive; Neg, negative.
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patients with mixed genotypes, showing a signiﬁcant correlation
(r = 0.821, p < 0.05); these genes in the esophagus were found in
55.0% and 65.0% of the 40 patients, also showing a signiﬁcant
correlation (r = 0.811, p < 0.05) (Table 2).
3.2. Histopathology of the gastric and esophageal mucosa
Of the 80 H. pylori-positive patients, it was possible to perform a
histopathological study of gastric biopsies for only 74 and of
esophageal biopsies for only 57. All 74 patients (100%) had
histopathological alterations in the antrum. Of these subjects, 14
(18.9%) showed acute inﬂammation characterized by neutrophil
and monocyte inﬁltration and bacteria, and 60 (81.0%) had varying
degrees of superﬁcial and chronic atrophic gastritis (Table 3).
Seventeen out of these 60 patients (28.3%) had superﬁcial gastritis
with or without dysplasia, with monocyte inﬁltration and bacteria
being the most frequent ﬁndings. On the other hand, 43 patientsTable 3
Histopathological results and frequencies in gastroesophageal mucosal biopsies from d
Histopathological alterations Gastric (n = 74) 
Acute inﬂammationa
n ((n/14)  100)
Superﬁcial gastritisa
n ((n/17)  100)
Dysplasia 0 (0) 10 (59%) 
Metaplasia 0 (0) 3 (18%) 
Inﬁltration 0 0 (0) 0 (0) 
Inﬁltration 1 13 (93%) 3 (18%) 
Inﬁltration 2 1 (7%) 7 (41%) 
Inﬁltration 3 0 (0) 7 (41%) 
Neutrophil inﬁltration 7 (50%) 9 (53%) 
Monocyte inﬁltration 8 (57%) 16 (94%) 
Malgun cells 2 (14%) 3 (18%) 
MALT-like follicles 1 (7%) 7 (41%) 
Bacteria 14 (100%) 17 (100%) 
Microabscesses - - 
Pseudogoblet cells - - 
Hyperplasia - - 
Plasmocytes - - 
MALT, mucosa-associated lymphoid tissue.
a n = numbers of patients with a given histopathological alteration found in 14, 17, a
stomach (antrum).
b n = numbers of patients with a given histopathological alteration found in 57 esop(71.7%) had chronic atrophic gastritis with or without dysplasia,
neutrophil inﬁltration, malgun (clear) cells, and bacteria (Table 3).
Other histopathological alterations, such as the presence of scarce
mucosa-associated lymphoid tissue (MALT)-like follicles, were
associated with gastritis and observed in 16 patients (22.0%)
(Table 3).
We found dysplasia, neutrophil inﬁltration, bacteria, micro-
abscesses, hyperplasia, and plasmocytes in all 57 (71.3%)
esophageal mucosa samples. Inﬁltration, microabscesses, and
hyperplasia were the most frequent alterations. The presence of
chronic inﬂammation in these 57 patients evidenced a marked
cellular immune response.
3.3. Relationship between different cag genotypes and
histopathological outcomes
We found signiﬁcant correlations between single or mixed cag
genotype proﬁles and different histopathological variables in each
mucosa on a per-patient basis. The correlation analysis of the intact
and deleted single cag genotypes with histopathological variables
in the gastric and esophageal mucosa is shown in Table 4.
The correlation analysis of the mixed cag genotypes on a per-
patient basis, i.e., intact cag genotype in the stomach and partial cag
genotype in the esophagus with the histopathological variables,
showed signiﬁcance between MALT-like follicles and inﬁltration 2
(r = 0.577, p < 0.05) (stomach) and between pseudogoblet cells and
metaplasia (r = 0.674, p < 0.05) (esophagus). The partial cag
genotype in the stomach, but deleted in the esophagus, showed
signiﬁcance between superﬁcial gastritis and reﬂux (r = 1, p < 0.01)
and chronic atrophic gastritis and reﬂux (r = 1, p < 0.05), while no
correlations were found in the esophagus.
4. Discussion
The present study of 150 symptomatic patients demonstrated
that the overall prevalence of H. pylori infection in the gastro-
esophageal mucosa was 64.7% (97 patients). Of these patients, we
found H. pylori infection in the esophagus of 82.5% (80 patients),
indicating that its colonization is linked to infection in the
stomach. Esophageal infection was correlated with different signs
of inﬂammation (pseudogoblet cells and metaplasia, microabs-
cesses and bacteria), as we have reported previously.14 Theyspeptic patients
Esophageal (n = 57)
n ((n/57)  100)b
Chronic atrophic gastritisa
n ((n/43)  100)
Total
n ((n/74)  100)
28 (65%) 38 (51%) 39 (68%)
2 (5%) 5 (7%) 9 (17%)
0 (0) 0 (0) -
5 (12%) 8 (11%) -
16 (37%) 24 (32%) -
23 (53%) 30 (41%) -
43 (100%) 59 (80%) 47 (82%)
28 (65%) 52 (70%) -
22 (51%) 72 (42%) -
8 (19%) 16 (22%) -
40 (93%) 71 (96%) 45 (79%)
- - 51 (89%)
- - 5 (9%)
- - 49 (86%)
- - 38 (67%)
nd 43 out of 74 patients according to the updated Sydney classiﬁcation for the
hageal biopsies.
Table 4
Analysis of signiﬁcant correlations between different histopathological variables in intact and deleted single cag genotype proﬁles from the same patient
Comparison among the different variables in the gastroesophageal mucosa Correlation signiﬁcance analysis by
Spearman’s rank
r p-Value
Intact single cag genotype Stomach
Dysplasia and presence of chronic atrophic gastritis 0.6 0.018a
Neutrophil inﬁltration and chronic atrophic gastritis 0.577 0.024a
Malgun cells and chronic atrophic gastritis 0.577 0.024a
Esophagus
Neutrophil inﬁltration and dysplasia 0.681 0.005b
Neutrophil inﬁltration and microabscesses 0.681 0.005b
Pseudogoblet cells and metaplasia 0.65 0.009b
Microabscesses and bacteria 0.65 0.009b
Deleted single cag genotype Stomach
Malgun cells and inﬁltration 2 0.745 0.034a
Esophagus
Plasmocytes and microabscesses 1 0.0001b
Neutrophil inﬁltration and bacteria 1 0.0001b
a p < 0.05.
b p < 0.01.
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in the esophageal mucosa might be linked to gastric acidity and/or
reﬂux.10,19 The relationship between H. pylori and reﬂux-related
disorders is controversial. Some studies have shown that reﬂux
diseases in cagA-positive H. pylori patients tend to be less severe
than in H. pylori-negative ones;20 however, others have reported
that H. pylori-positive patients with non-atrophic and atrophic
gastritis have an increased risk of esophageal adenocarcinoma and
esophageal squamous cell carcinoma.20 Our results demonstrate
an association between H. pylori and histopathological damage in
the esophagus.
H. pylori pathogenicity could be related not only to the presence
of the cagA gene, but also to other cag-PAI genes, which may have
pathogenic potential due to their critical functions. Indeed, virB11
participates in the assembling of the cag-PAI as a complex and
constitutes the minimum core structure necessary for type IV
transporter biogenesis.5 cagE is involved in the expression of
interleukin-8 in the gastric epithelial cells.21 Studies in a single
gastric biopsy and in a single-colony H. pylori isolated from the
same patient have shown different cag genotypes.6,7
We found frequencies in the stomach for an intact cag-PAI of
57.5%, partial of 21.3%, and deleted of 21.3%, whereas in the
esophagus these values were 33.8%, 33.8%, and 32.5%, respectively.
These results indicate that the intact cag-PAI is highly prevalent in
the stomach, while in the esophagus, intact or partial cag-PAI had
the same frequency of cagA-positive and negative strains. This
suggests a heterogeneous distribution in the esophagus, where H.
pylori strains may coexist in similar proportions with different cag
genotypes.
There is a remarkable genetic diversity among single- or
pooled-colony isolates and gastric biopsies, demonstrating geno-
typic variation among strains and variations in H. pylori popula-
tions within a single human host.6,7,22,23 This is in accordance with
the hypothesis that an intact cag-PAI in the stomach confers a
selective advantage to these H. pylori strains to colonize the highly
acidic gastric environment (pH 2.0). However, in the less acid
environment of the esophagus (pH 6.0), cagA-positive may not
have a selective advantage over the other strains, allowing the
colonization of strains with partial or deleted cag-PAI.6
When we assessed the distribution of cag genotype proﬁles in
the gastric and esophageal mucosae on a per-patient basis, it was
found that half of the individuals carried a single cag genotype,
whereas the other half carried a mixed cag genotype in both
mucosae (Table 2). In the single cag genotype proﬁle, the intact and
the deleted cag-PAI were the most prevalent (60.0% and 32.5%,respectively). The presence of H. pylori in both mucosae with the
same strain type suggests that the esophageal epithelium may
have been modiﬁed by changing its microenvironmental condi-
tions, making it similar to the stomach and allowing its
colonization by this bacterium.
In the mixed cag genotype proﬁle, cagA varied from 57.5% in the
stomach to 15.0% in the esophagus, while the cagE and virB11
genes showed similar frequencies between them by mucosa, with
signiﬁcant positive correlations. These correlations were higher in
the stomach than in the esophagus. These results suggest that both
genes are highly conserved within the cag-PAI, which is in
accordance with the fact that we showed an intact cag-PAI in 57.5%
(46 of 80 patients) with virulent genotypes in the stomach and
33.8% (27 of 80 patients) in the esophagus. The prevalence of cagE
and virB11 in the gastric mucosa is in accordance with previous
reports in dyspeptic patients with duodenal ulcer, and non-
atrophic or atrophic gastritis as being important factors for the H.
pylori pathogenesis.6,7,24,25 These authors found that cagE was
present in 73.7–96.6%6,7,24,25 of the cases, while virB11 was present
in 90.0–94.7%.6,7 In this study we show the occurrence of cagE and
virB11 in the esophageal mucosa for the ﬁrst time, indicating that
these genes can also be used as markers of cag-PAI in the
esophagus, as proposed by some authors for the cag island in the
stomach.6,7,25 The composition of the cag island in the mixed
genotype proﬁle, within the same individuals, in the stomach was
55.0%, 35.0%, and 10.0% for intact, partial, and deleted respectively,
while in the esophagus the prevalences were 7.5%, 60%, and 32.5%.
The variation in cag-PAI composition in the esophagus may be due
to adaptations of H. pylori to different microenvironmental
conditions than in the stomach (i.e., bacterial growth, host
immune response, and pH susceptibility), allowing growth
without selective advantage among strains, which could explain
its heterogeneity.
The frequency of the cagA gene was higher in the stomach (47/
80 patients; 58.8%) than in the esophagus (30/80 patients; 37.5%),
regardless of the single and mixed cag genotype proﬁle found
(Table 2). This difference in the prevalences indicates that cag
genotypes possess a higher virulence in the stomach in relation to
less virulent genotypes in the esophagus. In Venezuela, as in
occidental countries, H. pylori strains carrying Western type CagA
with EPIYA-C variants (ABC, ABCC, or ABCCC) have been
described.26–29 The number of these variants signiﬁcantly
increases the risk of developing severe gastritis and gastric
carcinoma. We found a stronger inﬂammation pattern in the
stomach of patients with chronic atrophic gastritis accompanied
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reported previously.14 The different histopathological correlations
were higher in intact and partial cag-PAI genotypes compared with
a deleted cag island in the stomach. This demonstrates that
the presence of virulence-associated genotypes is necessary for
the development of histopathological damage in the stomach.
Our results are in accordance with those of other studies
associating the presence of an intact cag-PAI with the development
of severe gastrointestinal damage, including gastric diseases and
cancer.4,6,23,30
To understand whether a relationship exists between single and
mixed cag genotypes and histopathological outcomes in both
mucosae, we assessed their correlations and found that the
presence of an intact single cag-PAI genotype was signiﬁcantly
associated with more severe damage in the gastric mucosa, as has
been observed in vacA s1m1/cagA genotypes in severe atrophic
gastritis.9 Dysplasia, microabscesses with neutrophil inﬁltration,
pseudogoblet cells and metaplasia, and microabscesses and
bacteria were found in the esophagus (Table 4). These results
indicate that a single cag-PAI genotype in both mucosae confers an
increased risk of developing histological damage.
In conclusion, our PCR-based study showed heterogeneity of
cag genotypes of H. pylori detected in the esophagus from the
population and on a per-patient basis. H. pylori may coexist in
similar proportions without dominance of one cag genotype. The
cagE and virB11 genes can be used as markers of cag-PAI in the
esophagus. A detailed genetic analysis of different colonies from a
single patient is required to establish the colonization by single or
multiple H. pylori strains in the esophagus.
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